ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
ZyVersa Therapeutics Inc

ZyVersa Therapeutics Inc (ZVSA)

1,07
-0,08
( -6,96% )
Mis à jour : 18:19:22

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
1,07
Prix Achat
1,07
Prix Vente
1,12
Volume échangé
75 391
1,06 Fourchette du Jour 1,1349
0,9801 Plage de 52 semaines 25,00
Cap du marché
Clôture Veille
1,15
Ouverture
1,11
Dernière Transaction
100
@
1.07
Dernière heure de transaction
18:19:21
Volume financier
US$ 83 098
VWAP
1,1022
Volume moyen (3 m)
1 373 895
Actions en circulation
2 344 191
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,50
Bénéfice par action (BPA)
-45,32
Chiffre d'affairess
-
Bénéfice net
-106,25M

À propos de ZyVersa Therapeutics Inc

ZyVersa Therapeutics Inc is a clinical stage specialty biopharmaceutical company that leverages advanced proprietary technologies to develop and commercialize first-in-class prescription drugs. The company's focus is on restoring health and improving quality of life for patients with high unmet medi... ZyVersa Therapeutics Inc is a clinical stage specialty biopharmaceutical company that leverages advanced proprietary technologies to develop and commercialize first-in-class prescription drugs. The company's focus is on restoring health and improving quality of life for patients with high unmet medical needs, with emphasis on inflammatory and renal diseases. Show more

Secteur
Pharmaceutical Preparations
Industrie
Blank Checks
Site Web
Siège social
Wilmington, Delaware, USA
Fondé
2022
ZyVersa Therapeutics Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker ZVSA. Le dernier cours de clôture d'ZyVersa Therapeutics était de US$1,15. Au cours de la dernière année, les actions de ZyVersa Therapeutics ont été négociées dans une fourchette de prix de US$ 0,9801 à US$ 25,00.

ZyVersa Therapeutics compte actuellement 2 344 191 actions en circulation. La capitalisation boursière d'ZyVersa Therapeutics est de US$2,70 million. ZyVersa Therapeutics a un ratio cours/bénéfice (ratio PE) de -0.50.

ZVSA Dernières nouvelles

ZyVersa Therapeutics’ CEO, Stephen C. Glover, to Attend JPM’s Healthcare Conference 2025 in San Francisco

ZyVersa is advancing a pipeline of first-in-class drug candidates built around two proprietary technologies. - Inflammasome ASC Inhibitor IC 100 designed to attenuate initiation and perpetuation...

ZyVersa Therapeutics Announces Peer-Reviewed Publication Demonstrating That Inflammasome ASC Inhibitor IC 100 Protects Against Stroke-Related Cardiovascular Injury and Dysfunction in Preclinical Trial

Strokes affect 795,000 people annually in the US. Obesity, a top risk factor for strokes, is associated with around one out of five strokes.Cardiac complications following a stroke are a leading...

Life Sciences Investor Forum: Presentations Now Available for Online Viewing

NEW YORK, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Sciences Investor...

ZyVersa Therapeutics Reports Third Quarter, 2024 Financial Results and Provides Business Update

KEY BUSINESS HIGHLIGHTS Phase 2a clinical trial for Cholesterol Efflux Mediator™ VAR 200 in patients with diabetic kidney disease expected to begin Q1-2025.New Obesity, Metabolic &...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.06-5.309734513271.131.28621881411.16874621CS
4-0.0158-1.455148277771.08581.420.98011635651.15138713CS
12-1.17-52.23214285712.243.370.980113738952.33649812CS
26-2.58-70.68493150683.656.30.98017064952.50830641CS
52-8.129-88.36830090239.199250.980111081917.11004613CS
156-4898.93-99.978163265349005232.50.9801196850179.92386347CS
260-4898.93-99.978163265349005232.50.9801196850179.92386347CS

ZVSA - Frequently Asked Questions (FAQ)

What is the current ZyVersa Therapeutics share price?
The current share price of ZyVersa Therapeutics is US$ 1,07
How many ZyVersa Therapeutics shares are in issue?
ZyVersa Therapeutics has 2 344 191 shares in issue
What is the market cap of ZyVersa Therapeutics?
The market capitalisation of ZyVersa Therapeutics is USD 2,7M
What is the 1 year trading range for ZyVersa Therapeutics share price?
ZyVersa Therapeutics has traded in the range of US$ 0,9801 to US$ 25,00 during the past year
What is the PE ratio of ZyVersa Therapeutics?
The price to earnings ratio of ZyVersa Therapeutics is -0,5
What is the reporting currency for ZyVersa Therapeutics?
ZyVersa Therapeutics reports financial results in USD
What is the latest annual profit for ZyVersa Therapeutics?
The latest annual profit of ZyVersa Therapeutics is USD -106,25M
What is the registered address of ZyVersa Therapeutics?
The registered address for ZyVersa Therapeutics is 108 W. 13TH STREET, SUITE 100, WILMINGTON, DELAWARE, 19801
What is the ZyVersa Therapeutics website address?
The website address for ZyVersa Therapeutics is www.zyversa.com
Which industry sector does ZyVersa Therapeutics operate in?
ZyVersa Therapeutics operates in the BLANK CHECKS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
NXUNXU Inc
US$ 1,6699
(586,07%)
421,64M
WATTEnergous Corporation
US$ 1,461
(255,30%)
164,41M
INTZIntrusion Inc
US$ 5,53
(156,02%)
114,5M
HOLOMicroCloud Hologram Inc
US$ 4,52
(88,33%)
99,55M
CYNCYNGN Inc
US$ 1,1699
(86,32%)
60,74M
ABPAbpro Holdings Inc
US$ 2,0501
(-54,34%)
1,39M
TRAWTraws Pharma Inc
US$ 7,825
(-41,69%)
896,28k
LITMSnow Lake Resources Ltd
US$ 1,1168
(-30,20%)
44,58M
LGHLWLion Group Holding Ltd
US$ 0,0052
(-25,71%)
54,82k
BITSGlobal X Blockchain and Bitcoin Stratagy ETF
US$ 66,74
(-24,56%)
8,96k
NXUNXU Inc
US$ 1,6699
(586,07%)
421,64M
VINCVincerx Inc
US$ 0,3519
(81,39%)
296,96M
XTIAXTI Aerospace Inc
US$ 0,0398
(0,76%)
184,49M
WATTEnergous Corporation
US$ 1,461
(255,30%)
164,41M
SMXSMX Security Matters Public Company
US$ 0,58
(64,03%)
132,06M
Aucune Discussion Trouvée
Ajouter une Discussion